Search Results
- < Prev
1 of 1
- Next >
News Releases
-
May 20, 2013, 11:44 ET
Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
Echo Pharma Acquisition Limited ("Royalty Pharma") today announced, pursuant to Rule 2.5 of the Irish Takeover Rules (the "Announcement"), a firm intention to increase its offer for Elan Corporation, plc (NYSE: ELN) to $12.50 per share in cash. The increased offer is fully financed,...
More news about: Royalty Pharma , Elan Corporation, plc , Echo Pharma Acquisition Limited
-
May 02, 2013, 07:03 ET
Royalty Pharma Submits Formal Cash Offer For Elan Corporation, plc ("Elan")
Echo Pharma Acquisition Limited ("Royalty Pharma") has today issued an offer document dated 2 May 2013 (the "Offer Document"). In the Offer Document, Royalty Pharma confirms the Offer Price set forth in its Rule 2.5 Announcement of 15 April (please see the Offer Document for...
More news about: Royalty Pharma , Elan Corporation, plc
-
Apr 18, 2013, 09:50 ET
Johnson & Johnson Announces Sale of Elan American Depositary Shares to Elan
Johnson & Johnson (NYSE: JNJ) today announced the sale to Elan Corporation, plc of approximately 82 million American Depositary Shares (ADS) of Elan held by Janssen Pharmaceutical (Janssen), an affiliate of Johnson & Johnson. This sale took place in accordance with the "Dutch...
More news about: Johnson & Johnson , Elan Corporation, plc , Janssen Pharmaceutical
- < Prev
1 of 1
- Next >
Modify your Search
| Quickly search for PR Newswire releases by adding our plugin to your browser search |
